Yuanchang Hu
- Cancer Research top 10%
- MicroRNA in disease regulation 2
-
- Sphingolipid Metabolism and Signaling 2
-
- Endoplasmic Reticulum Stress and Disease 3
- Hippo pathway signaling and YAP/TAZ 2
-
- Drug Transport and Resistance Mechanisms 2
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 2
-
- Phagocytosis and Immune Regulation 2
- Immune cells in cancer 2
- Journals
- Journal of Hepatology (1 paper)Cancer Letters (1 paper)Signal Transduction and Targeted Therapy (1 paper)
- Partner nations
- ChinaUnited KingdomTaiwan
In The Last Decade
Yuanchang Hu
11 papers receiving 499 citations
Hit Papers
Peers
Comparison fields: 5 of 61
- Cancer Research 221
- Molecular Biology 379
- Hepatology 33
- Cell Biology 65
- Oncology 71
Countries citing papers authored by Yuanchang Hu
This map shows the geographic impact of Yuanchang Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanchang Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanchang Hu more than expected).
Fields of papers citing papers by Yuanchang Hu
This network shows the impact of papers produced by Yuanchang Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanchang Hu. The network helps show where Yuanchang Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuanchang Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 26 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 13 | |
| 6 | 2022 | 0 | |
| 7 | 2021 | 16 | |
| 8 | HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translationbreakdown → | 2021 | 281 |
| 9 | 2020 | 16 | |
| 10 | 2020 | 18 | |
| 11 | 2019 | 25 | |
| 12 | 2019 | 54 | |
| 13 | 2018 | 50 | |
| 14 | 2018 | 0 |
About Yuanchang Hu
Yuanchang Hu is a scholar working on Cell Biology, Hepatology and Cancer Research, having authored 14 papers that have together received 502 indexed citations. Recurring topics across this work include Endoplasmic Reticulum Stress and Disease (3 papers), Drug Transport and Resistance Mechanisms (2 papers), MicroRNA in disease regulation (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Phagocytosis and Immune Regulation (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Immune cells in cancer (2 papers) and Sphingolipid Metabolism and Signaling (2 papers). The work is most often cited by research in Cancer Research (221 citations), Molecular Biology (379 citations) and Hepatology (33 citations). Yuanchang Hu has collaborated with scholars based in China, United Kingdom and Taiwan. Frequent co-authors include Xuehao Wang, Runqiu Jiang, Jiannan Qiu, Jinhai Tang, Qing Li, Liyong Pu, Yong Ni, Hong Yang, Liren Zhang and Jing Xu. Their work appears in journals such as Journal of Hepatology, Cancer Letters and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.